Atlas Copco AB
Atlas Copco AB (ACO1.F) Financial Performance & Income Statement Overview
Analyze Atlas Copco AB (ACO1.F) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Atlas Copco AB (ACO1.F) Income Statement & Financial Overview
Explore comprehensive income reports for Atlas Copco AB ACO1.F, broken down by year and quarter.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $45.99B | $43.10B | $44.80B | $42.88B |
| Cost of Revenue | $26.92B | $24.38B | $25.64B | $24.09B |
| Gross Profit | $19.07B | $18.73B | $19.16B | $18.78B |
| Gross Profit Ratio | $0.41 | $0.43 | $0.43 | $0.44 |
| R&D Expenses | $1.74B | $1.70B | $1.85B | $1.78B |
| SG&A Expenses | $8.11B | $7.42B | $7.98B | $7.59B |
| Operating Expenses | $9.05B | $9.39B | $9.82B | $9.38B |
| Total Costs & Expenses | $35.97B | $33.77B | $35.47B | $33.47B |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $50.00M | $0.00 | $0.00 |
| Depreciation & Amortization | $2.38B | $2.17B | $2.16B | $2.07B |
| EBITDA | $12.40B | $11.40B | $11.50B | $11.48B |
| EBITDA Ratio | $0.27 | $0.26 | $0.26 | $0.27 |
| Operating Income | $10.02B | $9.34B | $9.34B | $9.41B |
| Operating Income Ratio | $0.22 | $0.22 | $0.21 | $0.22 |
| Other Income/Expenses (Net) | -$37.00M | -$153.00M | -$63.00M | -$46.00M |
| Income Before Tax | $9.98B | $9.18B | $9.27B | $9.36B |
| Income Before Tax Ratio | $0.22 | $0.21 | $0.21 | $0.22 |
| Income Tax Expense | $2.18B | $2.01B | $1.63B | $2.19B |
| Net Income | $7.80B | $7.17B | $7.64B | $7.17B |
| Net Income Ratio | $0.17 | $0.17 | $0.17 | $0.17 |
| EPS | $1.60 | $1.47 | $1.57 | $1.47 |
| Diluted EPS | $1.60 | $1.47 | $1.57 | $1.47 |
| Weighted Avg Shares Outstanding | $4.87B | $4.87B | $4.87B | $4.87B |
| Weighted Avg Shares Outstanding (Diluted) | $4.88B | $4.88B | $4.88B | $4.88B |
Over the past four quarters, Atlas Copco AB demonstrated steady revenue growth, increasing from $42.88B in Q1 2024 to $45.99B in Q4 2024. Operating income reached $10.02B in Q4 2024, maintaining a consistent 22% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $12.40B, reflecting operational efficiency. Net income rose to $7.80B, with EPS at $1.60. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan